Navigation Links
GlaxoSmithKline To Cultivate Non-Smoking Environment

GlaxoSmithKline is putting its best foot forward in completing its social responsibility. The steps will also enable the company promote Zyban, its anti-smoking drug. Glaxo is aiding companies cultivate a non-smoking environment as part of its policy, along with providing teams to help in the transition. //

Some of the corporate, which have negotiated for this 'no-smoking' environment, are Housing Development Finance Corporation, the Godrej group, Bharat Petroleum Corporation Ltd., Siemens, Tata Power and The Associated Cement Companies.

The Company is providing for on-line registration for Indian corporate interested in promoting no-smoking culture among its employees. In a step-by-step process, Glaxo is charting out a detailed programme for the employees. The team comprises a doctor and a counsellor. It also includes free education programmes and counselling sessions and Zyban at discounted prices.

Glaxo has also been conducting smoking cessation camps all over Mumbai. Glaxo has also set up a helpline in order to quit smoking. Glaxo had targeted 50,000 patients for its first year with Zyban. It has already crossed the target of 10,000 patients. It had also sponsored the academic grant for the global initiative for obstructive lung disease in order to promote educating the public for chronic obstructive pulmonary disease at the National Conference on pulmonary diseases.

Currently, the drug is priced at Rs. 40 for a 150-mg tablet. The dosage is once a day for the first three days and from the fourth day, two tablets for seven weeks.
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. FDA Mislead On Asthma Drug By GlaxoSmithKline
4. GlaxoSmithKline Defends Its Products
5. GlaxoSmithKline launches diabetes and cancer drugs
6. Generic Products Compete With GlaxoSmithKline
7. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
8. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
9. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
10. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
11. GlaxoSmithKline Signs Outsourcing Deal With TCS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... and JENNERSVILLE, Pa. (PRWEB) , ... December 08, ... ... that Penn Medicine Southern Chester County, a Property owned by an affiliate of ... million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... for customers and employees that are both engaging and easy to use. Coming ... Technology, the software company revealed today its plans to roll out new AI-powered ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, ... to the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease ... CEO, Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... as possible. With this in mind, SIGVARIS has created a new line of ... during bed rest and provide the benefits of graduated compression when transitioning from ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 9, 2016  Forge Therapeutics, Inc. today announced ... Exchange: EVT, TecDAX, ISIN: DE0005664809) to advance its ... treatment of bacterial infections including those caused by ... an attractive antibacterial target for more than the ... chemical starting points has hampered its progress. Forge ...
(Date:12/8/2016)... Australia Ophthalmic Lasers Market Outlook to 2022 ... Market Outlook to 2022", provides key market data on ... in millions of US dollars, volume (in units) and ... Femtosecond Lasers and YAG Lasers. The report also ... of these market segements, and global corporate-level profiles of ...
(Date:12/8/2016)... Dec. 8, 2016 KEY FINDINGS ... Patient warming ... of blood during surgeries, lowering the risks of neurological disorders ... of SSIs. The patient warming systems can be segmented into ... benefits in turn reduce the stay at hospitals thus, lowering ...
Breaking Medicine Technology: